Healthy Skepticism Library item: 1886
Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.
Publication type: Journal Article
Huh J, Cude BJ.
Is the information
J Health Commun 2004 Nov-Dec; 9:(6):529-40
http://www.ncbi.nlm.nih.gov/pubmed/15764451
Abstract:
This study applies the Food and Drug Administration’s (FDA’s) “fair-balance disclosure” provision to examine the content of prescription drug websites, specifically focusing on the quantity and quality of risk information. The results show that even though most prescription drug websites provide both risk and benefit information, the two types of information are presented differently. This study suggests directions for regulators to consider in writing a more specific rule to ensure that information on prescription drug websites is balanced.
Keywords:
Advertising/legislation & jurisprudence
Advertising/standards*
Consumer Satisfaction*
Disclosure
Drug Industry/legislation & jurisprudence
Drug Industry/standards*
Drug Information Services/legislation & jurisprudence
Drug Information Services/standards*
Humans
Internet*
Patient Education
Prescriptions, Drug*
Risk
United States
United States Food and Drug Administration
